Use of micrornas to control virus helper nucleic acids
NZ582495A
Promoterless cassettes for expression of alphavirus structural proteins
AU2007317347A1
Alphavirus and alphavirus replicon particle formulations and methods
AU2007342333A1
Alphavirus replicon particles encoding IL- 12 as immunological adjuvants
AU2007296489A1
Alphavirus replicon particles matched to protein antigens as immunological adjuvants
AU2005245956A1
TC-83-derived alphavirus vectors, particles and methods
AU2004257214A1
Alphavirus-based cytomegalovirus vaccines
CN1791678A
Improved alphavirus replicons and helper constructs
NZ540657A
High-yielding, GMP-compatible, commercially feasible process for producing highly purified alphavirus replicon particle (ARP) preparations for use in human and veterinary medicine
AU2003297039A1
Multi-antigenic alphavirus replicon particles and methods
AU2003267971A8
Improved alphavirus vectors having attenuated virion structural proteins
WO03023026A1
Alphavirus replicon vector systems
US2002141975A1
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
AU7331301A
Alphavirus vectors and virosomes with modified hiv genes for use as vaccines
